High levels of MIF have also been reported in vivo in several cancer types including breast[5], lung[6] and gastric cancers[7] and the work of several groups points to a correlation between MIF expression and cancer prognosis, e.g. head and neck cancer and glioblastoma[8–10]. This evidence concerns the gene MIF and head and neck cancer.